New 2021 Forecasts Released

New Data
innovation hub

Mazal Plant Pharmaceuticals is Profiled in this Database

Updated At 03 Jan, 2012

Start Free 7 Day Trial Now
Partial description of this company
Developing healthier drugs from whole-plants. MAHDL, developed to elevate HDL-C, has undergone tests in man with positive results and has an IND from the FDA. Other whole-plant therapeutics are under development for dementia.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Mazal Plant Pharmaceuticals plus 4808 other startups.

Start Free 7 Day Trial Now

Learn More About Mazal Plant Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Our Clients